International Diabetes Federation supports study to foster improved control of type 2 diabetes

August 26, 2008

The International Diabetes Federation (IDF) BRIDGES translational research grant program will fund a diabetes self-management education study in Dallas.

Self-management education is an important component in diabetes care and designed to help people with diabetes to gain and maintain control of their condition. The Baylor Healthcare System (BHCS) project will add a motivational interviewing component to the diabetes education program to determine if this will improve program completion rates and help people with diabetes better manage their diabetes in the long-term.

The two-year project is a randomized controlled trial with adults who have uncontrolled type 2 diabetes. Certified Diabetes Educators will conduct the motivational interviewing training and education. Patients in the study will be followed to determine if the program has an impact on their diabetes control.

"This research will demonstrate the importance of facilitating self-initiated behavioural change to control diabetes. It will also indicate the significant potential for preventing diabetes complications and the impact of the patient-centered approach of motivational interviewing in improving the quality of life for persons with diabetes, said Dr. Robert Mayberry, the lead investigator.

Much of the day to day management of diabetes is done by the person who lives with the disease. Programs that help patients learn to make healthy decisions regarding their care are important in the prevention of the long-term complications related to the disease.

"Diabetes self-management programs are essential in the fight to prevent diabetes complications. Motivational interviews are an excellent addition to strengthen this important component of diabetes care," said Dr. Linda Siminerio, Chair of the IDF BRIDGES Review Committee.

The Federation, through BRIDGES, is committed to converting research findings into useful practices for the provision of quality care and services delivered by healthcare providers. The culturally specific education program in Texas, along with the 10 other selected translational research projects, was chosen because of its innovative idea, demonstration of the potential for health care cost savings, and the opportunity for its results to be widely replicated in other settings.

The International Diabetes Federation independently manages BRIDGES program with an educational grant from Eli Lilly and Company and is committed to promoting diabetes care, prevention and a cure worldwide.
-end-
Note to editors:

The International Diabetes Federation (IDF) is the global advocate for the over 250 million people with diabetes worldwide. It represents over 200 diabetes associations in more than 160 countries. Its mission is to promote diabetes care, prevention and a cure worldwide. Additional information is available at www.idf.org. Bringing Research in Diabetes to Global Environments and Systems (BRIDGES) is the global translational grant programme of the International Diabetes Federation. It solicits proposals that support cost effective and sustainable interventions that can be adopted in real world settings, for the prevention and control of diabetes. For more information, visit http://www.idfbridges.org.

Baylor Health Care System (BHCS) was founded in 1903 and is located in Dallas, Texas. It is one of the United States' largest integrated healthcare systems incorporating 14 hospitals and >100 primary and speciality ambulatory care centers. BHCS mission is to serve all people through exemplary healthcare, education, research and community service. Find out more at www.baylorhealth.com.

International Diabetes Federation

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.